One pilot study of patients with anti-citrullinated protein antibodies (ACPA)–positive arthralgia suggested that macrophage activation may potentially identify subclinical arthritis in patients who subsequently developed RA after 2 years (91). This evidence concerns the gene PRTN3 and arthritic joint disease.